Sydnexis
Phase 3Pediatric progressive myopia (PPM) is the leading cause of vision loss in children, with risks that extend far beyond the need for glasses, which address symptoms but do not treat the underlying disease. Yet treatment options remain limited — especially for younger children. At Sydnexis, we are focusing on a critical gap in care. We aim to advance innovation that can not only help preserve vision in growing eyes but may offer a new path forward for children and their families.
Private Company
Funding information not available
About
Pediatric progressive myopia (PPM) is the leading cause of vision loss in children, with risks that extend far beyond the need for glasses, which address symptoms but do not treat the underlying disease. Yet treatment options remain limited — especially for younger children. At Sydnexis, we are focusing on a critical gap in care. We aim to advance innovation that can not only help preserve vision in growing eyes but may offer a new path forward for children and their families.